HK1108115A1 - Sars vaccine based on replicative vaccinia virus vector - Google Patents

Sars vaccine based on replicative vaccinia virus vector

Info

Publication number
HK1108115A1
HK1108115A1 HK08101898A HK08101898A HK1108115A1 HK 1108115 A1 HK1108115 A1 HK 1108115A1 HK 08101898 A HK08101898 A HK 08101898A HK 08101898 A HK08101898 A HK 08101898A HK 1108115 A1 HK1108115 A1 HK 1108115A1
Authority
HK
Hong Kong
Prior art keywords
vaccinia virus
virus vector
vaccine based
replicative vaccinia
sars vaccine
Prior art date
Application number
HK08101898A
Other languages
English (en)
Inventor
Yiming Shao
Ying Liu
Yong Liu
Meng Sun
Jianyuan Liu
Ning Wang
Original Assignee
Nat Ct For Aids Std Control And Prevention China Cdc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Ct For Aids Std Control And Prevention China Cdc filed Critical Nat Ct For Aids Std Control And Prevention China Cdc
Publication of HK1108115A1 publication Critical patent/HK1108115A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK08101898A 2006-02-16 2008-02-21 Sars vaccine based on replicative vaccinia virus vector HK1108115A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2006100075662A CN101020055B (zh) 2006-02-16 2006-02-16 基于复制型痘苗病毒载体的sars疫苗

Publications (1)

Publication Number Publication Date
HK1108115A1 true HK1108115A1 (en) 2008-05-02

Family

ID=38371194

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08101898A HK1108115A1 (en) 2006-02-16 2008-02-21 Sars vaccine based on replicative vaccinia virus vector

Country Status (3)

Country Link
CN (1) CN101020055B (xx)
HK (1) HK1108115A1 (xx)
WO (1) WO2007093133A1 (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104293740B (zh) * 2013-07-18 2018-03-09 特菲(天津)生物医药科技有限公司 表面展示sars双价抗原的重组杆状病毒及其制备方法和应用
JP7128177B2 (ja) * 2016-08-02 2022-08-30 バクシネックス インコーポレーティッド ワクシニアウイルス／真核細胞においてポリヌクレオチドライブラリを生成するための改善された方法
WO2018085582A1 (en) 2016-11-02 2018-05-11 David Evans Synthetic chimeric poxviruses
WO2021147025A1 (en) * 2020-01-22 2021-07-29 The University Of Hong Kong-Shenzhen Hospital Anti 2019-ncov vaccine
JP2023515582A (ja) * 2020-02-26 2023-04-13 トニックス ファーマ リミテッド ＳＡＲＳ－ＣｏＶ－２ウイルスに対する、組換えポックスウイルスに基づくワクチン
CN113337481A (zh) * 2021-06-02 2021-09-03 中国医学科学院病原生物学研究所 一种基于痘苗病毒天坛株的新型冠状病毒疫苗
CN114874999B (zh) * 2022-04-22 2023-04-21 中国医学科学院病原生物学研究所 一种基于痘苗病毒载体的新型冠状病毒病毒样颗粒疫苗

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004091524A2 (en) * 2003-04-14 2004-10-28 Acambis Inc. Respiratory virus vaccines
US20070092936A1 (en) * 2003-05-08 2007-04-26 Haynes Barton F Severe acute respiratory syndrome
CN1276777C (zh) * 2003-05-21 2006-09-27 中山大学肿瘤防治中心 腺病毒载体sars疫苗及其制备方法，冠状病毒s基因的应用
CN100438918C (zh) * 2003-06-16 2008-12-03 中国科学院动物研究所 一种抗sars病毒的基因疫苗及其用途
CN100386343C (zh) * 2003-07-03 2008-05-07 李越希 Sars病毒s蛋白与n蛋白的融合蛋白及其制备、应用

Also Published As

Publication number Publication date
CN101020055A (zh) 2007-08-22
CN101020055B (zh) 2012-08-08
WO2007093133A1 (fr) 2007-08-23

Similar Documents

Publication Publication Date Title
IL195683A0 (en) Recombinant viral vaccine
EP1909829A4 (en) RECOMBINANT GRIP VACCINES
GB0504436D0 (en) Vaccine
IL196024A0 (en) Influenza vaccine
IL210742A0 (en) Novel viral vector
SI2043682T1 (sl) Influenčno cepivo
EP2091960A4 (en) PEPTIDE VACCINE AGAINST INFLUENZA VIRUS
HK1108115A1 (en) Sars vaccine based on replicative vaccinia virus vector
EP2048232A4 (en) NON-REPLICATIVE PARAMYXOVIRIDAE VIRUS VECTOR
ZA200809056B (en) Influenza virus vaccine
EP2117589A4 (en) FLAVIVIRUS VACCINE VECTOR AGAINST INFLUENZA VIRUS
ZA201104013B (en) Recombinant inactivated viral vector vaccine
EP1871786A4 (en) PEPTIDE VACCINE AGAINST THE GRIPPEVIRUS
ZA200709605B (en) HIV vaccine
EP2054081A4 (en) VACCINE AGAINST THE JC VIRUS
EP1907537A4 (en) PREPARATIONS BASED ON PARAMYXOVIRIDAE VIRUS
EP1992358A4 (en) VACCINE AGAINST AIDS BASED ON REPLICATIVE VACCINIA VECTOR VECTOR
EP1872794A4 (en) NASAL VACCINE
ZA200807552B (en) Recombinant mononegaviral virus vectors
ZA200804099B (en) Multiclade HIV vaccines
EP2154246A4 (en) VIRAL VECTOR AND ITS USE
ZA200900062B (en) Influenza vaccine
ZA200810625B (en) Recombinant viral vaccine
IL191977A0 (en) Improved influenza vaccine
GB0623865D0 (en) Influenza vaccine